Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
- 1 August 1999
- journal article
- case report
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 22 (8) , 1267-1269
- https://doi.org/10.1111/j.1540-8159.1999.tb00614.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- IbutilideDrugs, 1997
- Efficacy of Ibutilide for Termination of Atrial Fibrillation and FlutterThe American Journal of Cardiology, 1996
- Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/FlutterThe American Journal of Cardiology, 1996
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response studyJournal of the American College of Cardiology, 1996
- Electrophysiologic characteristics of human atrial muscle in paroxysmal atrial fibrillationAmerican Heart Journal, 1996
- Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K + Current (I Kr ) in AT-1 CellsCirculation, 1995
- Risk of Sudden Arrhythmic Death in the Wolff-Parkinson-White Syndrome: Current PerspectivesPacing and Clinical Electrophysiology, 1994
- Diagnosis and management of the preexcitation syndromesCurrent Problems in Cardiology, 1988
- Paroxysmal atrial fibrillation in the wolff-parkinson-white syndromeThe American Journal of Cardiology, 1981
- Ventricular Fibrillation in the Wolff-Parkinson-White SyndromeNew England Journal of Medicine, 1979